FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2700711000001104: Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1273661000001115 Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1273671000001113 Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Is a Megestrol 160mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Is pack of Megace 160mg tablets (Bausch & Lomb UK Ltd) false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has active ingredient Megestrol acetate false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has active ingredient Antineoplastic agent false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has AMP Megace 160mg tablets (Bausch & Lomb UK Ltd) true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has specific active ingredient Megestrol acetate true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Bausch & Lomb UK Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start